Sfoglia per Autore
Malattie epatiche focali nel paziente epatopatico
2005 M. Colombo, A. Sangiovanni
Basi scientifiche per la definizione di linee-guida in ambito clinico per l’epatocarcinoma
2005 M. Colombo
Clinico-pathological features of hepatocellular carcinoma
2005 M. Colombo, G. Ronchi
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants
2005 A. Marzano, P. Lampertico, V. Mazzaferro, S. Saia, M. Viganò, R. Romito, A. Pulvirenti, A. Franchello, M. Colombo, M. Salizzoni, M. Rizzetto
L’epatite cronica C, l’ottimizzazione della terapia
2005 A. Alberti, M. Colombo, A. Craxì, F. Piccinino, M. Rizzetto
Successful treatment of hepatocellular carcinoma (hcc) with transchateter arterial embolization (tae) with microspheres (embosphere)
2005 A. Nicolini, A. Sangiovanni, P. Fasani, L. Forzenigo, G.M. Prati, R. Romeo, S. Crespi, G. Ronchi, P. Biondetti, M. Colombo
La malattia epatica da virus C : una condizione guaribile. Storia naturale
2005 M. Colombo
Interferon-alpha suppresses liver cell proliferation in patients with chronic hepatitis C virus infection
2005 M.F. Donato, C. Degott, E. Arosio, M. Martinot, V. Monti, A. Morabito, P. Marcellin, M. Colombo
Welcome Editorial
2005 M. Colombo
Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B
2005 P. Lampertico, M. Viganò, E. Manenti, G. Lunghi, M.A. Iavarone, E. Del Ninno, M. Colombo
Natural history of hepatocellular carcinoma
2005 M. Colombo
Membro Editorial Board di Hepatology
2005
Membro editorial board di The Lancet. Edizione italiana
2005
Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy
2005 P. Lampertico, M. Viganò, E. Manenti, G. Lunghi, M.A. Iavarone, G. Colucci, M. Colombo
Barcelona Clinic liver cancer (BCLC) stage is a better survival predictor than cancer of the liver Italian program (CLIP) in patients with hepatocellular carcinoma
2005 A. Sangiovanni, E. Molteni, R. Romeo, P. Fasani, G. Ronchi, C. De Fazio, E. Del Ninno, C. Vergani, M. Colombo
Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
2005 P. Lampertico, M. Viganò, E. Manenti, G. Lunghi, M.A. Iavarone, E. Del Ninno, M. Colombo
Prevention of hepatocellular carcinoma
2005 M.G. Colombo, M.F. Donato
Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c : a retrospective cohort study of 206 untreated patients
2005 M.G. Rumi, F. De Filippi, C. La Vecchia, M.F. Donato, S. Gallus, E. Del Ninno, M. Colombo
Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
2005 D. Prati, A. Colli, D. Conte, M. Colombo
Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation
2005 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, M. Colombo, G. Lambertenghi Deliliers, P. Lampertico
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile